Professor Marilyn James

Professor of Applied Health Economics

e-mail Tel No: 0151 231 4213

Prof Marilyn James BA (Hons), MSc, Ph.D, is Professor of Applied Health Economics at Liverpool John Moores University and Liverpool Primary Care Trust.

She is economic advisor to the Department of Health’s National Screening Committee Ante Natal Sub Group. She is the Health Economist to the National Diabetic Retinopathy Network. She was founding head of the Health Economics (R&D) Unit at the Centre for Health Planning and Management, Keele University since 1995.

After completing her MSc, Marilyn gained practical knowledge of the health service by working in a variety of posts both at district and unit level across the NHS.  During her doctoral studies she was employed as the health economist to West Lancashire Health Authority.  Between 2001 and 2004 she gained commercial experience whilst on secondment to AstraZeneca pharmaceuticals working as senior global health economist. She worked on mega brand drugs and the design and delivery of major international trials, taking Crestor through the reimbursement process with a number of Prescription Pricing Authorities.

She has for many years provided technical and policy advice to the Regional R&D directorates in the field of health economics.  Marilyn’s primary objective for her research is applied economic evaluation.  Her current research portfolio is wide and is concentrated upon the practical application of economic evaluation in a number of research settings.  These include evaluation in pharmaceuticals, nutritional support, orthopaedics, orthotics, ophthalmology, where she has been involved in preparing part of the National Service Framework in screening for diabetic eye disease, A&E medicine, obstetrics and gynaecology.  In addition, she has applied cost utility analysis using both the Rosser QALY and the EuroQol indices to assist purchasers in making prioritisation decisions. Research funding has been obtained from the Department of Health, Research Councils, Charities, Regional Health Authorities, District Health Authorities through to individual practitioners. She has published and presented widely in the field of clinical and economic evaluation and applying health economics to policy issues. Her book on “Harnessing Information for Health Economics Analysis” (2006) takes the reader through the practical challenges and approaches of using and obtaining health economics information.

Prof Marilyn James BA (Hons), MSc, Ph.D, is Professor of Applied Health Economics at Liverpool John Moores University and Liverpool Primary Care Trust.

She is economic advisor to the Department of Health’s National Screening Committee Ante Natal Sub Group. She is the Health Economist to the National Diabetic Retinopathy Network. She was founding head of the Health Economics (R&D) Unit at the Centre for Health Planning and Management, Keele University since 1995.

After completing her MSc, Marilyn gained practical knowledge of the health service by working in a variety of posts both at district and unit level across the NHS.  During her doctoral studies she was employed as the health economist to West Lancashire Health Authority.  Between 2001 and 2004 she gained commercial experience whilst on secondment to AstraZeneca pharmaceuticals working as senior global health economist. She worked on mega brand drugs and the design and delivery of major international trials, taking Crestor through the reimbursement process with a number of Prescription Pricing Authorities.

She has for many years provided technical and policy advice to the Regional R&D directorates in the field of health economics.  Marilyn’s primary objective for her research is applied economic evaluation.  Her current research portfolio is wide and is concentrated upon the practical application of economic evaluation in a number of research settings.  These include evaluation in pharmaceuticals, nutritional support, orthopaedics, orthotics, ophthalmology, where she has been involved in preparing part of the National Service Framework in screening for diabetic eye disease, A&E medicine, obstetrics and gynaecology.  In addition, she has applied cost utility analysis using both the Rosser QALY and the EuroQol indices to assist purchasers in making prioritisation decisions. Research funding has been obtained from the Department of Health, Research Councils, Charities, Regional Health Authorities, District Health Authorities through to individual practitioners. She has published and presented widely in the field of clinical and economic evaluation and applying health economics to policy issues. Her book on “Harnessing Information for Health Economics Analysis” (2006) takes the reader through the practical challenges and approaches of using and obtaining health economics information.